EUVIMEDEUVIMED entdecken
Crossref

CRISPR/Cas-Based Electrochemical Biosensor for Human Immunodeficiency Virus-1 Nucleic Acid Amplification-Free Detection to the Attomolar Level

Lingxuan Qu, Lingyi Meng, Xilin Sun, Wei Cui, Jin Shi, Yuqi Wang, Qingshuang Hu, Shuping Xu iD, Bingxin Sun, Chongyang Liang iD

ACS Sensors · 22.08.2025 · 10 (8) · 5613-5622

DOI: 10.1021/acssensors.5c00363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Sensors, online erschienen am 04.08.2025. Verfasst von Lingxuan Qu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmacy, School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130021, China. Hauptthemen laut MEDLINE: Biosensing Techniques, HIV-1, Electrochemical Techniques, CRISPR-Cas Systems. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Key Research and Development Program of China, State Key Laboratory of Supramolecular Structure and Materials, Department of Science and Technology of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aiming at realizing field detection during HIV-1 patient screening in developing countries and point of care testing (POCT) of virus levels in HIV-1 patients receiving medication, an urgent demand for portable nucleic acid detection technology with low cost and sensitivity is raised. To solve this, a CRISPR/Cas13a-based electrochemical detection platform by a multiple combined crRNAs strategy is developed. This sensing platform is based on the Ion Current Rectification regulation through a Porous Anodic Alumina membrane decorated with ssRNA chains, which are trans-cleavage substrates for activated Cas13a and become shorter when the target gene exists, resulting in an altered motion of transmembrane ions. This platform was proven to be feasible and ultrasensitive for tracing the HIV-1 virus by multiple applicable crRNAs combination, and its clinical sample detection limit arrives at 60 copies/μL for HIV-1 patients' serum samples. Importantly, this method is amplification-free, and its sensitivity is beyond the nonamplification fluorescence-based nucleic acid strategy by one order of magnitude. This sensor is facile to use and cost-effective, and can also be extended to other RNA-based pathogenic microorganism detections. This POCT method facilitates self-monitoring of drug resistance in HIV-1 patients, regardless of medication status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesHIV-1Electrochemical TechniquesCRISPR-Cas SystemsRNA, ViralHumansLimit of DetectionNucleic Acid Amplification TechniquesHIV Infections

Stichwörter der Autor:innen

CRISPR/Cas13aHIV-1/AIDSamplification-freeelectrochemical technologiespoint of careporous anodic aluminaportable electrochemical sensorserum-based diagnostics

Substanzen

RNA, Viral

Autor:innen und Institutionen

  • Department of Biopharmacy, School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130021, China.
  • Institute of Microbiology, Changchun Disease Control and Prevention Center, Changchun, Jilin 130033, China.
  • State Key Laboratory of Supramolecular Structure and Materials, Institute of Theoretical Chemistry, College of Chemistry, Jilin University, Changchun, Jilin 130021, China.

ORCID-Profile: Shuping Xu, Chongyang Liang

Förderung

  • National Key Research and Development Program of China
  • State Key Laboratory of Supramolecular Structure and Materials
  • Department of Science and Technology of Jilin Province
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China

Zitieren

APA

Qu, L., Meng, L., Sun, X., Cui, W., Shi, J., Wang, Y., Hu, Q., Xu, S., Sun, B., & Liang, C. (2025). CRISPR/Cas-Based Electrochemical Biosensor for Human Immunodeficiency Virus-1 Nucleic Acid Amplification-Free Detection to the Attomolar Level. ACS Sensors, 10(8), 5613-5622. https://doi.org/10.1021/acssensors.5c00363

Vancouver

Qu L, Meng L, Sun X, Cui W, Shi J, Wang Y, et al. CRISPR/Cas-Based Electrochemical Biosensor for Human Immunodeficiency Virus-1 Nucleic Acid Amplification-Free Detection to the Attomolar Level. ACS Sensors. 2025;10(8):5613-5622. doi:10.1021/acssensors.5c00363

BibTeX
@article{Qu2025,
  author = {Qu, Lingxuan and Meng, Lingyi and Sun, Xilin and Cui, Wei and Shi, Jin and Wang, Yuqi and Hu, Qingshuang and Xu, Shuping and Sun, Bingxin and Liang, Chongyang},
  title = {CRISPR/Cas-Based Electrochemical Biosensor for Human Immunodeficiency Virus-1 Nucleic Acid Amplification-Free Detection to the Attomolar Level},
  journal = {ACS Sensors},
  year = {2025},
  volume = {10},
  number = {8},
  pages = {5613--5622},
  doi = {10.1021/acssensors.5c00363}
}
Kostenlos starten →